|
Volumn 33, Issue 1-2, 2001, Pages 1701-1703
|
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
GRAFT REJECTION;
HUMAN;
KIDNEY TRANSPLANTATION;
MALE;
OUTCOMES RESEARCH;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
ACUTE DISEASE;
ADULT;
ANTIBODIES, MONOCLONAL;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOCORTICOIDS;
GRAFT REJECTION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
PREDNISONE;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
SURVIVAL RATE;
TACROLIMUS;
|
EID: 0035083873
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02649-X Document Type: Conference Paper |
Times cited : (9)
|
References (5)
|